Goldman Sachs Upgrades Align Tech to Neutral, Announces $307 Price Target

Goldman Sachs analyst Nathan Rice upgrades Align Tech (NASDAQ:ALGN) from Sell to Neutral and announces $307 price target.

byBenzinga Newsdesk

February 2, 2023

1 minute read

Goldman Sachs analyst Nathan Rice upgrades Align Tech (NASDAQ:ALGN) from Sell to Neutral and announces $307 price target.

FDA
News

BioSig Says Completes 1000 Patient Cases With Its Signal Processing System For Electrophysiology

By Benzinga Newsdesk

June 30, 9:35 AM

BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal

BSGM

Analyst Ratings

Where Dick’s Sporting Goods Stands With Analysts

By Benzinga Insights

August 26, 12:32 PM

Over the past 3 months, 11 analysts have published their opinion on Dick's Sporting Goods (NYSE:DKS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

DKS

Morgan Stanley Maintains Underweight on Cheesecake Factory, Lowers Price Target to $38

By Benzinga Newsdesk

January 14, 9:59 AM

Morgan Stanley analyst John Glass maintains Cheesecake Factory (NASDAQ:CAKE) with a Underweight and lowers the price target from $43 to $38.

CAKE

Xylem Expands Partnership With Imagine H2O To ‘Support Water Innovation Entrepreneurs’

By Benzinga Newsdesk

October 21, 8:26 AM

Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world's greatest water challenges has announced an expanded commitment to Imagine H2O, the leading water innovation

XYL

Goldman Sachs Upgrades Align Tech to Neutral, Announces $307 Price Target

Related Posts

BioSig Says Completes 1000 Patient Cases With Its Signal Processing System For Electrophysiology

Where Dick’s Sporting Goods Stands With Analysts

Morgan Stanley Maintains Underweight on Cheesecake Factory, Lowers Price Target to $38

Xylem Expands Partnership With Imagine H2O To ‘Support Water Innovation Entrepreneurs’